---
title: "在醫療保險排除減肥藥物覆蓋後，禮來和諾和諾德公司的股票暴跌。特朗普政府的新政策未將它們納入覆蓋範圍"
description: "週五，特朗普政府宣佈了最終的醫療保險和醫療補助政策，導致禮來股票下跌。減肥藥物的排除使得禮來和諾和諾德公司的股票大幅下滑。該決定對市場產生了重大影響，禮來的股票價值明顯下降"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/234617274.md"
published_at: "2025-04-04T22:52:16.000Z"
---

# 在醫療保險排除減肥藥物覆蓋後，禮來和諾和諾德公司的股票暴跌。特朗普政府的新政策未將它們納入覆蓋範圍

> 週五，特朗普政府宣佈了最終的醫療保險和醫療補助政策，導致禮來股票下跌。減肥藥物的排除使得禮來和諾和諾德公司的股票大幅下滑。該決定對市場產生了重大影響，禮來的股票價值明顯下降

週五，特朗普政府宣佈了最終的醫療保險和醫療補助政策，導致禮來公司的股票下跌。減肥藥的排除導致禮來和諾和諾德公司的股票大幅下滑。該決定對市場產生了重大影響，禮來的股票價值明顯下降。

### Related Stocks

- [NVO.US - 諾和諾德公司](https://longbridge.com/zh-HK/quote/NVO.US.md)
- [LLY.US - 禮來](https://longbridge.com/zh-HK/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk A/S kauft Einheiten im Wert von rund DKK 222,297,903 zurück | Novo Nordisk A/S has repurchased units worth approximately DKK 222,297,903 as part of a buyback program. This announceme | [Link](https://longbridge.com/zh-HK/news/275315179.md) |
| Novo Nordisk A/S repurchases units for DKK 222 million | Novo Nordisk A/S has repurchased 750,000 B shares for approximately DKK 222 million at an average price of 296.40 DKK pe | [Link](https://longbridge.com/zh-HK/news/275315124.md) |
| Novo Nordisk Launches Weight Loss Pill Across US | Novo Nordisk Launches Weight Loss Pill Across US | [Link](https://longbridge.com/zh-HK/news/274912821.md) |
| Novo Nordisk CEO Mike Doustdar Plans To Bring "Wegovy High-Dose" To Market As Soon As Possible - CNBC Interview | NOVO NORDISK CEO MIKE DOUSTDAR: PLANS TO BRING "WEGOVY HIGH-DOSE" TO THE MARKET AS SOON AS POSSIBLE- CNBC INTERVIEW | [Link](https://longbridge.com/zh-HK/news/274884174.md) |
| Novo Nordisk Says FDA Approves Ozempic Pill, Set to be Available in US in Q2 | Novo Nordisk Says FDA Approves Ozempic Pill, Set to be Available in US in Q2 | [Link](https://longbridge.com/zh-HK/news/274849748.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。